Top GLP-1 Drugs Out-Earn OpenAI and Anthropic Combined

Social Capital data shows the two biggest GLP-1 weight-loss drugs will earn about $71B in 2025, roughly twice the combined revenue of OpenAI and Anthropic, despite AI dominating headlines.

2026-10-11 ~ 2026-10-12 · 3 related posts

• Top two GLP-1 drugs already outearn OpenAI and Anthropic combined — adam_dorr · 2026-10-11
• Two Biggest GLP-1 Drugs Bring In ~2x the Combined Revenue of OpenAI and Anthropic — FinanceYF5 · 2026-10-12
• Social Capital: GLP-1 Duopoly Revenue ~2x OpenAI and Anthropic Combined — FinanceYF5 · 2026-10-12